• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉化静脉移植物中白细胞介素-1β的激活及-511C/T白细胞介素-1β基因多态性的影响

Activation of Interleukin-1 Beta in Arterialized Vein Grafts and the Influence of the -511C/T IL-1β Gene Polymorphism.

作者信息

Miyakawa Ayumi Aurea, Borin Thaiz Ferraz, Campos Luciene Cristina Gastalho, Girão-Silva Thais, Ribeiro-Silva Joao Carlos, Dallan Luis Alberto Oliveira, Krieger Jose Eduardo

机构信息

Heart Institute (InCor), University of São Paulo Medical School, São Paulo, SP 05403-000, Brazil.

出版信息

J Cardiovasc Dev Dis. 2019 Apr 30;6(2):20. doi: 10.3390/jcdd6020020.

DOI:10.3390/jcdd6020020
PMID:31052244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6616868/
Abstract

The interleukin-1 family is associated with innate immunity and inflammation. The latter has been linked to the genesis of cardiovascular diseases. We, therefore, investigated whether interleukin-1 beta (IL-1β) is activated during arterialization of vein grafts. First, we examined the activation of IL-1β using the rat arterialized jugular vein serially sampled for up to 90 days. IL-1β expression increased 18 times on day 1 in the arterialized rat jugular vein and remained five times above nonarterialized vein levels for up to 90 days. Similarly, IL-1β expression increased early (1-5 days) in human vein graft autopsy samples compared with late phases (1-4 years). Activation was also detected in ex vivo arterialized human saphenous veins. Upon stratification of the results, we uncovered a T allele promoter attenuating effect in IL-1β activation in response to hemodynamic stress. Altogether, the results show that IL-1β is activated during arterialization of vein grafts in rats and humans, and this response is modulated by -511C/T IL-1β gene polymorphism. It is tempting to speculate that the activation of IL-1β, and consequently local inflammation, modulates early vascular remodeling and that the gene polymorphism may be useful in predicting outcomes or assisting in interventions.

摘要

白细胞介素-1家族与先天免疫和炎症相关。后者已被证明与心血管疾病的发生有关。因此,我们研究了在静脉移植物动脉化过程中白细胞介素-1β(IL-1β)是否被激活。首先,我们使用连续采样长达90天的大鼠动脉化颈静脉来检测IL-1β的激活情况。在动脉化的大鼠颈静脉中,IL-1β表达在第1天增加了18倍,并在长达90天的时间内保持在非动脉化静脉水平的5倍以上。同样,与后期阶段(1 - 4年)相比,人静脉移植物尸检样本中的IL-1β表达在早期(1 - 5天)增加。在体外动脉化的人隐静脉中也检测到了激活。在对结果进行分层时,我们发现了一个T等位基因启动子在IL-1β对血流动力学应激的激活中具有减弱作用。总体而言,结果表明在大鼠和人的静脉移植物动脉化过程中IL-1β被激活,并且这种反应受到IL-1β基因-511C/T多态性的调节。很容易推测,IL-1β的激活以及由此导致的局部炎症会调节早期血管重塑,并且该基因多态性可能有助于预测结果或辅助干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1a/6616868/037423476db6/jcdd-06-00020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1a/6616868/b12d709ce443/jcdd-06-00020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1a/6616868/037423476db6/jcdd-06-00020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1a/6616868/b12d709ce443/jcdd-06-00020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed1a/6616868/037423476db6/jcdd-06-00020-g002.jpg

相似文献

1
Activation of Interleukin-1 Beta in Arterialized Vein Grafts and the Influence of the -511C/T IL-1β Gene Polymorphism.动脉化静脉移植物中白细胞介素-1β的激活及-511C/T白细胞介素-1β基因多态性的影响
J Cardiovasc Dev Dis. 2019 Apr 30;6(2):20. doi: 10.3390/jcdd6020020.
2
Temporal Change of Extracellular Matrix during Vein Arterialization Remodeling in Rats.大鼠静脉动脉化重塑过程中细胞外基质的时间变化
J Cardiovasc Dev Dis. 2019 Feb 2;6(1):7. doi: 10.3390/jcdd6010007.
3
Anti-inflammatory and anti-proliferative effects of CBS3830 in arterialized vein grafts in rats.CBS3830对大鼠动脉化静脉移植物的抗炎和抗增殖作用。
Immunopharmacol Immunotoxicol. 2014 Dec;36(6):397-403. doi: 10.3109/08923973.2014.956754. Epub 2014 Sep 10.
4
Wall shear modulation of cytokines in early vein grafts.早期静脉移植物中细胞因子的壁面剪切调节
J Vasc Surg. 2004 Aug;40(2):345-50. doi: 10.1016/j.jvs.2004.03.048.
5
Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians.北印度人群中白细胞介素-1β(-511C/T)和白细胞介素-1受体拮抗剂(86bp重复序列)基因多态性与2型糖尿病的遗传关联。
Clin Chim Acta. 2007 Feb;377(1-2):163-9. doi: 10.1016/j.cca.2006.09.012. Epub 2006 Oct 27.
6
Association of interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in Turkish children with atopic asthma.土耳其特应性哮喘儿童白细胞介素-1β和白细胞介素-1受体拮抗剂基因多态性的关联
Allergy Asthma Proc. 2008 Sep-Oct;29(5):468-74. doi: 10.2500/aap.2008.29.3154.
7
Altered expression of vascular endothelial growth factor and its receptors in normal saphenous vein and in arterialized and stenotic vein grafts.
Am J Surg. 2003 Nov;186(5):561-8. doi: 10.1016/j.amjsurg.2003.07.023.
8
Vein graft arterialization causes differential activation of mitogen-activated protein kinases.静脉移植物动脉化导致丝裂原活化蛋白激酶的差异性激活。
J Thorac Cardiovasc Surg. 2004 May;127(5):1276-84. doi: 10.1016/j.jtcvs.2003.07.017.
9
Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins.血流动力学在人隐静脉体外动脉化中的作用。
J Vasc Surg. 2013 May;57(5):1371-82. doi: 10.1016/j.jvs.2012.09.041. Epub 2013 Jan 23.
10
Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis.人隐静脉平滑肌细胞中透明质酸合酶亚型的差异调节:对静脉移植物狭窄的潜在影响。
Circ Res. 2006 Jan 6;98(1):36-44. doi: 10.1161/01.RES.0000199263.67107.c0. Epub 2005 Dec 8.

本文引用的文献

1
Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice.白细胞介素-1β对小鼠晚期动脉粥样硬化病变具有保护作用。
Nat Med. 2018 Sep;24(9):1418-1429. doi: 10.1038/s41591-018-0124-5. Epub 2018 Jul 23.
2
Inflammation in Vein Graft Disease.静脉移植物疾病中的炎症
Front Cardiovasc Med. 2018 Jan 24;5:3. doi: 10.3389/fcvm.2018.00003. eCollection 2018.
3
Canakinumab for Residual Inflammatory Risk.卡那单抗用于降低残余炎症风险。
Eur Heart J. 2017 Dec 21;38(48):3545-3548. doi: 10.1093/eurheartj/ehx723.
4
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.卡那单抗治疗后 C 反应蛋白降低与心血管事件减少的关系:来自 CANTOS 随机对照试验的二次分析。
Lancet. 2018 Jan 27;391(10118):319-328. doi: 10.1016/S0140-6736(17)32814-3. Epub 2017 Nov 13.
5
The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology.CANTOS 试验:临床心脏病学的重要一步,但也是血管生物学的巨大飞跃。
Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):e174-e177. doi: 10.1161/ATVBAHA.117.310097. Epub 2017 Sep 28.
6
Activation and inflammation of the venous endothelium in vein graft disease.静脉移植物疾病中静脉内皮的激活和炎症。
Atherosclerosis. 2017 Oct;265:266-274. doi: 10.1016/j.atherosclerosis.2017.08.023. Epub 2017 Aug 24.
7
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
8
Association Between Platelet to Lymphocyte Ratio and Saphenous Vein Graft Disease.血小板与淋巴细胞比值和隐静脉移植血管病变之间的关联
Angiology. 2016 Feb;67(2):133-8. doi: 10.1177/0003319715578258. Epub 2015 Mar 29.
9
EuroSCORE II with SYNTAX score to assess risks of coronary artery bypass grafting outcomes.采用欧洲心脏手术风险评估系统II(EuroSCORE II)和SYNTAX评分来评估冠状动脉旁路移植术的预后风险。
Eur J Cardiothorac Surg. 2015 Jan;47(1):66-71. doi: 10.1093/ejcts/ezu045. Epub 2014 Mar 5.
10
Vein graft failure.静脉移植物失败。
J Vasc Surg. 2015 Jan;61(1):203-16. doi: 10.1016/j.jvs.2013.08.019. Epub 2013 Oct 3.